These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36910617)

  • 1. Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinoma.
    Cheng PY; Lee HY; Li WM; Huang SK; Liu CL; Chen IA; Lin JT; Lo CW; Yu CC; Wang SS; Chen CS; Tseng JS; Lin WR; Yeong-Chin J; Cheong IS; Jiang YH; Lee YK; Chen YT; Chen SH; Chiang BJ; Hsueh TY; Huang CY; Wu CC; Lin WY; Tsai YC; Yu KJ; Huang CP; Huang YY; Tsai CY
    Front Oncol; 2023; 13():944321. PubMed ID: 36910617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New classification of hydronephrosis on 18F-FDG-PET/CT predicts post-operative renal function and muscle-invasive disease in patients with upper urinary tract urothelial carcinoma.
    Asai S; Fukumoto T; Watanabe R; Koyama K; Sawada Y; Noda T; Miura N; Yanagihara Y; Miyauchi Y; Miyagawa M; Kikugawa T; Saika T
    Jpn J Clin Oncol; 2018 Nov; 48(11):1022-1027. PubMed ID: 30252103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma.
    Hashimoto T; Ohno Y; Nakashima J; Gondo T; Nakagami Y; Namiki K; Horiguchi Y; Yoshioka K; Ohori M; Tachibana M
    Jpn J Clin Oncol; 2015 Nov; 45(11):1064-8. PubMed ID: 26355160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative hydronephrosis is associated with less decline in renal function after radical nephroureterectomy for upper tract urothelial carcinoma.
    Singla N; Hutchinson R; Haddad A; Sagalowsky A; Lotan Y; Margulis V
    Can J Urol; 2016 Aug; 23(4):8334-41. PubMed ID: 27544555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.
    Xylinas E; Rink M; Margulis V; Clozel T; Lee RK; Comploj E; Novara G; Raman JD; Lotan Y; Weizer A; Roupret M; Pycha A; Scherr DS; Seitz C; Ficarra V; Trinh QD; Karakiewicz PI; Montorsi F; Zerbib M; Shariat SF;
    BJU Int; 2013 Aug; 112(4):453-61. PubMed ID: 23464979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative hydronephrosis: independent predictor for changes in renal function following nephroureterectomy.
    Hoshino K; Kikuchi E; Tanaka N; Akita H; Ito Y; Miyajima A; Jinzaki M; Oya M
    Jpn J Clin Oncol; 2012 Mar; 42(3):202-7. PubMed ID: 22246718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy.
    Lane BR; Smith AK; Larson BT; Gong MC; Campbell SC; Raghavan D; Dreicer R; Hansel DE; Stephenson AJ
    Cancer; 2010 Jun; 116(12):2967-73. PubMed ID: 20564402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smaller decline of renal function after nephroureterectomy predicts poorer prognosis of upper tract urothelial carcinoma: a multicentre retrospective study.
    Yamada Y; Nakagawa T; Miyakawa J; Kawai T; Tabata M; Kaneko T; Taguchi S; Naito A; Hikatsu M; Sato Y; Murata T; Matsumoto A; Miyazaki H; Suzuki M; Enomoto Y; Nishimatsu H; Kondo Y; Takeuchi T; Tanaka Y; Kume H
    Jpn J Clin Oncol; 2021 Oct; 51(10):1577-1586. PubMed ID: 34047345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
    Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma.
    Kaag M; Trost L; Thompson RH; Favaretto R; Elliott V; Shariat SF; Maschino A; Vertosick E; Raman JD; Dalbagni G
    BJU Int; 2014 Nov; 114(5):674-9. PubMed ID: 24314050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: A multicenter retrospective study.
    Okuyama Y; Hatakeyama S; Tabata R; Fujimori D; Kawashima Y; Tanaka T; Fujita N; Okamoto T; Mori K; Yamamoto H; Yoneyama T; Hashimoto Y; Matsuoka T; Sato S; Ohyama C
    Int J Urol; 2023 Aug; 30(8):649-657. PubMed ID: 37130800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma.
    Leow JJ; Martin-Doyle W; Fay AP; Choueiri TK; Chang SL; Bellmunt J
    Eur Urol; 2014 Sep; 66(3):529-41. PubMed ID: 24680361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute kidney injury strongly influences renal function after radical nephroureterectomy for upper tract urothelial carcinoma: A single-centre experience.
    Tafuri A; Odorizzi K; Di Filippo G; Cerrato C; Fassio G; Serafin E; Princiotta A; D'Aietti D; Gozzo A; Porcaro AB; Brunelli M; Cerruto MA; Antonelli A
    Arch Ital Urol Androl; 2021 Mar; 93(1):9-14. PubMed ID: 33754601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Value of Preoperative Local Symptoms in Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Retrospective, Multicenter Cohort Study.
    Yeh HC; Chang CH; Fang JK; Chen IA; Lin JT; Hong JH; Huang CY; Wang SS; Chen CS; Lo CW; Yu CC; Tseng JS; Lin WR; Jou YC; Cheong IS; Jiang YH; Tsai CY; Hsueh TY; Chen YT; Huang HC; Tsai YC; Lin WY; Wu CC; Lin PH; Lin TW; Wu WJ
    Front Oncol; 2022; 12():872849. PubMed ID: 35719933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer.
    Song W; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
    Urol Oncol; 2017 Mar; 35(3):114.e1-114.e7. PubMed ID: 27908680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for impaired renal function following nephroureterectomy in upper urinary tract urothelial cell carcinoma.
    Rodríguez Faba O; Palou J; Breda A; Maroto P; Fernández Gómez JM; Wong A; Villavicencio H
    Urol Int; 2014; 92(2):169-73. PubMed ID: 24280761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native Kidney Hydronephrosis Is Associated with Upper Urinary Tract Urothelial Carcinoma in Post-Kidney Transplantation Patients.
    Ho CJ; Huang YH; Hsieh TY; Yang MH; Wang SC; Chen WJ; Lee TH; Sung WW; Chen SL
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome.
    Yafi FA; Tanguay S; Rendon R; Jacobsen N; Fairey A; Izawa J; Kapoor A; Black P; Lacombe L; Chin J; So A; Lattouf JB; Bell D; Fradet Y; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Kassouf W
    Urol Oncol; 2014 Jan; 32(1):31.e17-24. PubMed ID: 23428535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram predicting renal insufficiency after nephroureterectomy for upper tract urothelial carcinoma in the Chinese population: exclusion of ineligible candidates for adjuvant chemotherapy.
    Fang D; Zhang Q; Li X; Qian C; Xiong G; Zhang L; Chen X; Zhang X; Yu W; He Z; Zhou L
    Biomed Res Int; 2014; 2014():529186. PubMed ID: 25180185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium).
    Tafuri A; Marchioni M; Cerrato C; Mari A; Tellini R; Odorizzi K; Veccia A; Amparore D; Shakir A; Carbonara U; Panunzio A; Trovato F; Catellani M; Janello LMI; Bianchi L; Novara G; Dal Moro F; Schiavina R; De Lorenzis E; Parma P; Cimino S; De Cobelli O; Maiorino F; Bove P; Crocerossa F; Cantiello F; D'Andrea D; Di Cosmo F; Porpiglia F; Ditonno P; Montanari E; Soria F; Gontero P; Liguori G; Trombetta C; Mantica G; Borghesi M; Terrone C; Del Giudice F; Sciarra A; Galosi A; Moschini M; Shariat SF; Di Nicola M; Minervini A; Ferro M; Cerruto MA; Schips L; Pagliarulo V; Antonelli A
    World J Urol; 2022 Nov; 40(11):2771-2779. PubMed ID: 36203101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.